The universal role of YB-1 in various solid tumors and its secretion by tumor cells prompted the current study in which we tested for the first time the potential clinical and diagnostic value of YB-1 or its fragments in human plasma in cohorts of healthy volunteers and patients with malignant as well as non-malignant diseases, using a novel immunoblotting system. The gene discussed is YBX1; the disease is neoplasm.